All

All
Insight
Research Services
Preclinical CRO
Animal Resource Bank

The tech expert is here! Let’s head over to Jiangsu Provincial Second Traditional Chinese Medicine Hospital to chat about all things research.

Jiangsu Aniphe BioLab Inc. was established in 2018 and is committed to becoming an internationally renowned preclinical pharmacodynamic evaluation company in the new era of biopharmaceutical development. The company has built a comprehensive SPF‑grade laboratory animal facility that integrates animal production and experimental research.

Aniphe BioLab focuses on the fields of laboratory animals and animal‑based research services, offering a comprehensive portfolio that includes contract breeding and husbandry, strain preservation and pathogen clearance for genetically edited models, the generation of human disease models, and pharmacological and toxicological testing services—covering multiple research areas such as oncology, neuroscience, and metabolism. The company has established long-term collaborations with numerous research institutions and innovative pharmaceutical companies. For instance, in partnership with Zhengzhou University and East China Normal University, it has developed standardized methodologies and workflows for gene editing in mice and rats, as well as for gene editing and cloning in miniature pigs, and for generating surgical and chemically induced disease models. Ailinfei also maintains a full suite of behavioral assessment systems for small animals and advanced imaging platforms for mice, ensuring the smooth execution of preclinical efficacy studies.

Aniphe BioLab remains market‑driven, upholding the principles of pragmatism, truth‑seeking, and mutual benefit. By integrating industry, academia, and research, it fosters R&D innovation, serving the fields of biological research and the new‑drug development industry, thereby contributing to human health and well‑being.

None!

Your mouse has arrived! We deliver mice right to your door—just for you!